US Patent Issued to AC Immune on June 16 for "Mimotopes of alpha-synuclein and vaccines thereof for the treatment of synucleinopathy" (Austrian Inventors)

ALEXANDRIA, Va., June 16 -- United States Patent no. 12,653,872, issued on June 16, was assigned to AC Immune SA (Lausanne, Switzerland).

"Mimotopes of alpha-synuclein and vaccines thereof for the treatment of synucleinopathy" was invented by Markus Mandler (Vienna), Harald Weninger (Vienna), Radmila Santic (Vienna) and Edith Kopinits (Landegg, Austria).

According to the abstract* released by the U.S. Patent & Trademark Office: "A method of treating a synucleinopathy with a peptide (C)DQPVLPD (SEQ ID NO: 59), (C)DMPVLPD (SEQ ID NO: 60), (C)DSPVLPD (SEQ ID NO: 61), (C)DQPVLPDN (SEQ ID NO: 64), (C)DMPVLPDN (SEQ ID NO: 65), (C)DSPVLPDN (SEQ ID NO: 66), (C)HDRPVTPD (SEQ ID NO: 70), (C)DRPVTPD (SEQ ID NO: 71), (C)DVPVLPD (SEQ ID NO: 72), (C)DT...